H.C. Wainwright Downgrades Prelude Therapeutics (PRLD) to Neutral

February 20, 2024 6:10 AM EST Send to a Friend
(Updated - February 20, 2024 6:38 AM EST)

H.C. Wainwright analyst Robert Burns downgraded Prelude Therapeutics (NASDAQ: PRLD) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login